Giacomo Lus

3.5k total citations
85 papers, 950 citations indexed

About

Giacomo Lus is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Giacomo Lus has authored 85 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pathology and Forensic Medicine, 30 papers in Neurology and 17 papers in Oncology. Recurrent topics in Giacomo Lus's work include Multiple Sclerosis Research Studies (49 papers), Peripheral Neuropathies and Disorders (20 papers) and Polyomavirus and related diseases (10 papers). Giacomo Lus is often cited by papers focused on Multiple Sclerosis Research Studies (49 papers), Peripheral Neuropathies and Disorders (20 papers) and Polyomavirus and related diseases (10 papers). Giacomo Lus collaborates with scholars based in Italy, France and United States. Giacomo Lus's co-authors include Elisabetta Signoriello, Roberta Lanzillo, Vincenzo Brescia Morra, Simona Bonavita, Roberto Cotrufo, Mariarosa Anna Beatrice Melone, Francesco Saccà, Simone Sampaolo, Antonio Carotenuto and Gioacchino Tedeschi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Giacomo Lus

73 papers receiving 932 citations

Peers

Countries citing papers authored by Giacomo Lus

Since Specialization

Citations

This map shows the geographic impact of Giacomo Lus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giacomo Lus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giacomo Lus more than expected).

Fields of papers citing papers by Giacomo Lus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giacomo Lus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giacomo Lus. The network helps show where Giacomo Lus may publish in the future.

Co-authorship network of co-authors of Giacomo Lus

This figure shows the co-authorship network connecting the top 25 collaborators of Giacomo Lus. A scholar is included among the top collaborators of Giacomo Lus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giacomo Lus. Giacomo Lus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis	Non-coding RNA Research	Elisabetta Signoriello, Giuseppe Romano et al.	0
2	Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 ⁺ T-Cell Proliferation in Patients With Multiple Sclerosis	Neurology Neuroimmunology & Neuroinflammation	Gianmarco Abbadessa, Maria Teresa Lepore et al.	4
3	Normative values of the brief international cognitive assessment for multiple sclerosis (BICAMS) in an Italian young adolescent population: the influence of age, sex, and education	Neurological Sciences	Fabrizia Falco, Luigi Trojano et al.	1
4	Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study	Journal of Neurology	Aurora Zanghì, Giovanna Borriello et al.	6
5	Comparing face-to-face and videoconference assessment of the Brief Repeatable Battery of Neuropsychological Tests in people with multiple sclerosis	Multiple Sclerosis Journal	Simona Raimo, Gabriella Santangelo et al.	3
6	Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study	Multiple Sclerosis Journal - Experimental Translational and Clinical	Gıancarlo Comı, Letizia Leocani et al.	4
7	Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)	Multiple Sclerosis and Related Disorders	Teresa Costabile, Elisabetta Signoriello et al.	7
8	Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches	Journal of Clinical Medicine	Maria Teresa Gentile, Gianluca Muto et al.	4
9	Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective	Neurological Sciences	Giacomo Lus, Vincenzo Brescia Morra et al.	3
10	Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy	Multiple Sclerosis Journal	Elisabetta Signoriello, Giacomo Lus et al.	13
11	CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab	International Journal of Environmental Research and Public Health	Gianmarco Abbadessa, Giuseppina Miele et al.	15
12	Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project	Pharmaceuticals	Giorgia Teresa Maniscalco, Vincenzo Brescia Morra et al.	7
13	Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery	PLoS ONE	Marcello Moccia, Elisabetta Signoriello et al.	16
14	Migraine as possible red flag of PFO presence in suspected demyelinating disease	Journal of the Neurological Sciences	Elisabetta Signoriello, Mario Cirillo et al.	10
15	Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis	Quantitative Imaging in Medicine and Surgery	Ferdinando Caranci, Giacomo Lus et al.	5
16	Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study	Journal of Neurology	Pietro Annovazzi, Marco Capobianco et al.	40
17	Lipid Abnormalities in Patients with Different Degrees of Chronic Renal Failure	Contributions to nephrology	Bruno Cianciaruso, Bruno Memoli et al.	0
18	Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing— remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy	Multiple Sclerosis Journal	Roberta Lanzillo, Giuseppe Orefice et al.	65
19	Azathioprine and Interferon β<sub>1a</sub> in Relapsing-Remitting Multiple Sclerosis Patients: Increasing Efficacy of Combined Treatment	European Neurology	Giacomo Lus, Roberto Cotrufo et al.	27
20	Abnormal Accumulation of tTGase Products in Muscle and Erythrocytes of Chorea-Acanthocytosis Patients	Journal of Neuropathology & Experimental Neurology	Mariarosa Anna Beatrice Melone, Giuseppe Di Fede et al.	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact